HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Benzetimide

HCID 21847
NotesReactions
Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
14051-33-3
Standard SMILES
O=C1CCC(c2ccccc2)(C2CCN(Cc3ccccc3)CC2)C(=O)N1
InChIKey
LQQIVYSCPWCSSD-UHFFFAOYSA-N
Molecular formula
C23H26N2O2
Average molar mass
362.5 g/mol
Monoisotopic mass
362.19942808

Overview

Benzetimide is a member of piperidines.

Names & identifiers

Preferred name
Benzetimide
IUPAC
3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione
English name
3-(1-benzyl-4-piperidyl)-3-phenyl-piperidine-2,6-dione
Molecular formula
C23H26N2O2
Molecular weight
362.46

Names & synonyms

Benzetimide14051-33-3BenzetimidumSpasmentalbencetimida2-(1-Benzyl-4-piperidyl)-2-phenylglutarimideDTXSID2046173B987T0L5FXDTXCID00261732-[1-BENZYL-4-PIPERIDYL]-2-PHENYLGLUTARIMIDE(3,4'-Bipiperidine)-2,6-dione, 3-phenyl-1'-(phenylmethyl)-RefChem:118121
Show more names
Benzezimida( -)-BenzetimidBENZETIMIDE(WXG01746)Benzetimidum [inn-latin]Benzezimida [inn-spanish]3-Phenyl-1'-(phenylmethyl)-3,4'-bipiperidine-2,6-dione3-(1-benzyl-4-piperidyl)-3-phenyl-piperidine-2,6-dione(Rs)-3-(1-benzyl-4-piperidyl)-3-phenyl-2,6-piperidindion
Benzetimide [INN]3-(1-benzylpiperidin-4-yl)-3-phenylpiperidine-2,6-dione1'-Benzyl-3-phenyl-[3,4'-bipiperidine]-2,6-dioneBenzetimide (INN)119391-55-8CHEMBL10272MFCD00242705(+/-)-Benzetimide

Database identifiers

CAS

Properties

Computed structural properties

XLogP
3.1
Topological polar surface area
49.4 Ų
Hydrogen bond donors
1
Hydrogen bond acceptors
3
Rotatable bonds
4
Heavy atoms
27
Formal charge
0
Complexity
528

Physicochemical properties

Melting point
156 · 156-159°
FDA UNII
987 T0L5FX · B987T0L5FX

Chemistry & industry

Pharmacology

ATC CodeQA - Alimentary tract and metabolism
MeSH Pharmacological Classification · 3 items

Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists.

Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS.

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system.

Upstream & downstream products

Downstream products

3-phenyl-[3,4-bipiperidine]-2,6-dione(WXG01747)

Suppliers1 total

上海凯裕医药科技有限公司17317130613 · [email protected]

Additional notes

DefinitionChEBI: Benzetimide is a member of piperidines.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
14051-33-3
PubChem CID
21847
DTXSID
DTXSID2046173
ChEMBL
CHEMBL10272
ChEBI
CHEBI:188883
UNII
B987T0L5FX
Nikkaji
J8.476J